Elanco Animal Health Incorporated ELAN
22.31
(0.04)
(0.18%)
as of 25 Sep
- Market cap
- $11.2B
- P/E
- 0.0×
Follow ELAN
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (2.98%) | (3.77%) | (3.67%) | 0.54% |
+8 more TTM periods Free account |
|
| (1.46%) | (1.85%) | (1.79%) | 0.27% | ||
ROIC |
0.51% | 0.35% | 0.09% | 1.21% | |
Return on Tangible Assets |
(5.93%) | (7.30%) | (7.09%) | 1.05% | |
Average Days of Receivables |
83.76 | 86.08 | 72.77 | 77.52 | |
Free Cash Flow per Share |
0.76 | 0.63 | 0.57 | 0.74 | |
Free Cash Flow |
379.00 | 315.00 | 284.00 | 368.00 | |
Capital Expenditures |
(238.00) | (262.00) | (276.00) | (261.00) | |
Piotroski F-Score |
5.00 | 5.00 | 5.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
5.59% | 5.28% | 5.04% | 5.58% | |
Accounts Receivable Turnover |
4.45 | 4.42 | 5.16 | 4.89 | |
Accounts Payable Turnover |
5.64 | 6.27 | 6.39 | 6.77 | |
Inventory Turnover |
1.30 | 1.33 | 1.28 | 1.24 | |
Average Days of Payables |
69.55 | 61.75 | 63.30 | 62.13 | |
Days of Inventory on Hand |
288.12 | 285.00 | 298.78 | 301.46 | |
Tax Rate |
0.20 | 0.23 | 0.04 | (3.25) | |
Research and Development Expense of Revenue |
7.39% | 7.58% | 7.80% | 7.75% | |
Selling, General and Administrative Expense of Revenue |
30.26% | 30.04% | 30.33% | 30.32% | |
Share Based Compensation of Revenue |
1.47% | 1.51% | 1.44% | 1.46% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(3.10) | (2.38) | (2.41) | 17.47 | |
Depreciation/Fixed assets |
0.49 | 0.50 | 0.48 | 0.48 | |
Capex/Depreciation |
(0.34) | (0.38) | (0.41) | (0.39) | |
Revenue per Share |
10.05 | 9.83 | 9.50 | 9.24 | |
Operating CF per Share |
1.24 | 1.16 | 1.13 | 1.27 | |
Capex per Share |
(0.48) | (0.53) | (0.56) | (0.53) | |
Capex to Sales |
0.05 | 0.05 | 0.06 | 0.06 | |
Net Profit Margin |
(3.96%) | (4.95%) | (4.92%) | 0.78% |
Columns are period end dates